Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1977 of 5804
-
Cancer patients who respond to drug get continued access in new study
Disease control ENROLLING_BY_INVITATIONThe rationale of the ROSY-D study is to continue to provide study treatment for patients who have participated in a parent study with Durvalumab and who are continuing to derive clinical benefit from treatment at the end of such studies, as judged by the Investigator.
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New scanner could spot dangerous brain bleeds without radiation
Diagnosis CompletedMOBI-1 is a multicenter clinical trial that will evaluate the use of the Infrascanner for the monitoring of traumatic intracranial hematomas.
Sponsor: University of Alabama at Birmingham • Aim: Diagnosis
Last updated Jun 26, 2026 12:54 UTC
-
Smartwatch and ring take on the 12-Lead ECG in heart rhythm showdown
Diagnosis CompletedAtrial fibrillation (AF) is the most common arrhythmia (irregular heart rhythm), affecting 1-2 million people in the UK. AF significantly increases the risk of an AF-related stroke, heart failure and dementia. A significant proportion of people will have no symptoms, and they may…
Phase: NA • Sponsor: Oxford University Hospitals NHS Trust • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New drug shows promise for ARDS patients in major trial
Disease control CompletedNeutrophil elastase (NE) released by neutrophils play an important role in inflammatory cascade and lung tissue injury of ARDS.Inhibition of NE is expected to prevent the pathophysiological process of ARDS and alleviate lung injury. Siverestat sodium is a specific inhibitor of NE…
Phase: PHASE4 • Sponsor: Sichuan Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New PET tracer aims to sharpen prostate cancer detection
Diagnosis Recruiting nowProstate-specific membrane antigen (PSMA)-targeted PET imaging with 68Ga-labeled compounds is able to provide superior sensitivity and specificity to detect primary prostate tumor and its metastases, like the most widely studied 68Ga-PSMA-11. This pilot study was evaluate the dia…
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
New MRI technique could reveal how well lung treatments are working
Diagnosis OngoingThe purpose of this multi-centered, NIH-sponsored study is to to develop an optimal protocol for using non-invasive 129Xe gas exchange MRI to detect changing disease activity in interstitial lung diseases (ILDs). We base this study on the demonstrated promise of 129Xe as a biomar…
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
Could a smart bra help spot breast cancer early?
Diagnosis OngoingThis project aims to assess the ability of a portable and connected medical device to detect breast abnormalities, for breast cancer screening. It will accelerate technological progress in the face of breast cancer.
Phase: NA • Sponsor: Hopital Nord Franche-Comte • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
New drug combo targets Hard-to-Treat HER2 cancers
Disease control Recruiting nowThis first-in-human (FIH) Phase 1 open-label multicenter dose-escalation and dose-expansion study is designed to evaluate the safety, pharmacokinetics, and preliminary activity of VIR-5818 (Formerly AMX-818) as a single agent and in combination with pembrolizumab in participants …
Phase: PHASE1, PHASE2 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New insulin shows promise for type 1 diabetes in chinese trial
Disease control CompletedThis is a 26-week randomized, open-label, multicenter, active-controlled parallel group trial. The purpose of this study is to compare efficacy and safety of THDB0206 injection with insulin lispro injection combined with insulin glargine injection U-100 in Chinese participants wi…
Phase: PHASE3 • Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Asthma inhaler switch may help patients breathe easier, study finds
Disease control CompletedThe goal of asthma management is to achieve and maintain optimal asthma control. The NEWTON study assesses the evolution over time of patient reported outcomes (PROs) in asthmatic patients, not adequately controlled with ongoing treatments and initiating therapy with extrafine be…
Sponsor: Chiesi Italia • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Virtual reality may replace some sedatives during knee surgery
Symptom relief CompletedThe objective of this study is to investigate whether the use of virtual reality (VR) during total knee arthroplasty (TKA) can facilitate reductions in intraoperative sedative requirements while maintaining high levels of patient satisfaction as compared to both a music and sham …
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
HIV study: could shots beat pills for reducing hidden virus and inflammation?
Knowledge-focused Recruiting nowIn the last 40 years of HIV history, we have managed to attain most of our therapeutic objectives, namely virological suppression of most patients and sufficient immune reconstitution. Still, immune activation and inflammation persist and even if they decrease on ART (AntiRetrovi…
Sponsor: Hôpital Européen Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Personalized antibiotics may beat standard therapy for stubborn stomach bug
Disease control Recruiting nowThe prevalence of H. pylori antibiotic resistance has reached an alarming level worldwide. Antibiotic stewardship programs should be urgently developed and implemented. However, H. pylori antimicrobial susceptibility testing (AST) is rarely offered, making local resistance patter…
Phase: PHASE4 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Kidney transplant patients get extra COVID shot in new trial
Disease control TerminatedThe purpose of this research is to see if a dose of the Janssen Ad26.CoV2.S vaccine effects the immune protection in individuals who have had a kidney transplant and two or three doses of mRNA vaccine (Pfizer and/or Moderna vaccines).
Phase: PHASE3 • Sponsor: Mark Stegall • Aim: Disease control
Last updated Jun 26, 2026 17:26 UTC
-
Brain and eye tests could revolutionize autism research
Knowledge-focused CompletedThis is a multicenter longitudinal study that aims to validate a set of measures that were previously identified as promising candidate biomarkers and/or sensitive and reliable objective measures of social function in ASD for potential use in clinical trials. The confirmation stu…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:31 UTC
-
Could a new PET tracer reveal hidden brain changes in dementia?
Knowledge-focused CompletedThis study will compare the discriminative power of \[18F\]-SynVesT-1 PET and the standard-of-care \[18F\]-FDG PET in different cognitive disorders (Alzheimer's disease, Frontotemporal degeneration, dementia with Lewy bodies and late-life psychiatric disorders). Moreover, changes…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Could a Sugar-Water injection ease knee arthritis?
Symptom relief CompletedThe purpose of this research is to learn more about treating Symptomatic Knee Osteoarthritis (OA) with an ultrasound-guided hypertonic dextrose injection. Researchers would like to determine best practice for injection frequency and effectiveness of the dextrose injection for sym…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New magnesium membrane could boost dental implant success
Disease control CompletedThe NOVAMag® membrane is a medical device approved in the EU, and is a completely resorbable and biodegradable metal membrane. This medical device is used in the treatment of bone defects in the oral cavity. The membrane ensures sufficient stability of the bone augmentation mater…
Phase: NA • Sponsor: Botiss Medical AG • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New study tracks COVID-19 vaccine response in young cancer patients
Knowledge-focused OngoingThis study evaluates immunologic response following COVID-19 vaccination in children, adolescents, and young adults with cancer. Vaccines work by stimulating the body's immune cells to respond against a specific disease. The immune response produces protection from that disease. …
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Sugar-Free diet may shield hispanic kids from fatty liver
Prevention TerminatedThis is a 2 year clinical trial testing an intensive intervention to reduce dietary sugars as a means to prevent non-alcoholic fatty liver disease (NAFLD) in pre-pubertal Hispanic children.
Phase: NA • Sponsor: Emory University • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC